Study: Pre-Launch Spending Aids Drug Companies

Jan. 13, 2005
Compiled By Traci Purdum Early market research investment in pharmaceuticals, which starts as early as the pre-clinical stage, drives long-term market preparation and competitiveness, according to a recent study by Cutting Edge Information, a ...
Compiled ByTraci Purdum Early market research investment in pharmaceuticals, which starts as early as the pre-clinical stage, drives long-term market preparation and competitiveness, according to a recent study by Cutting Edge Information, a pharmaceutical intelligence firm based in Durham, N.C. According to the study "Pre-Launch Pharmaceutical Market Research: Decision Support for New Product Development," the average support for a developing product is $7.1 million. Top-spending organizations dedicate more than $26 million to their market research initiatives. Despite the large support investment, pre-launch spending represents only 28% of overall market research investment. "Pharmaceutical market research teams are enjoying a rebirth in strategic responsibility," says Jason Richardson, Cutting Edge Information's CEO. "By holding back pre-launch budgets, however, companies are missing the opportunity to strategically position their products and grow the market years before launch." The study contains more than 250 metrics and details how top companies allocate resources, develop strategy and conduct effective market research activities. It also contains market research budgets, staffing, strategies and tactics from 17 top pharmaceutical companies including Pfizer, AstraZeneca, Eli Lilly, Bristol-Myers Squibb and Aventis. To download the online summary of the 141-page report, visit www.pharmamarketresearch.com.

Popular Sponsored Recommendations

Top 3 Ways AI is Transforming Manufacturing Operations

Feb. 17, 2024
Unlock the power of Industry 4.0 with AI and IoT. Explore how real-time data and automation are reshaping manufacturing, driving efficiency and quality to new heights. Dive into...

From Data to Action: Enabling the Connected Enterprise with a Digital Thread

Feb. 8, 2024
Manufacturers are transforming the enterprise with cloud technologies and IoT

Onsite Wind Generation Guide for C&I

Jan. 22, 2024
This document offers insights into using onsite wind power for businesses, covering feasibility, project development, technology selection, and benefits of renewable energy.

Executive Summary: Enterprise Resource Planning Manages Manufacturing Risk and Uncertainty in 2024

Jan. 4, 2024
Explore the future of manufacturing in 2024 by discovering how cloud-based ERP systems can help manufacturers thrive amidst supply chain disruptions and economic uncertainty.

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!